Related Experiment Video
Updated: Aug 5, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
The Acute Dialysis Quality Initiative--part VI: access and anticoagulation in CRRT
Andrew Davenport1, Sangeeta Mehta
1Department of Nephrology, Royal Free Hospital, London, United Kingdom. andrew.davenport@rfh.nthames.nhs.uk
Abstract:
Both the choice of vascular access and anticoagulant regimen for continuous renal replacement therapy (CRRT) are a major determinant of not only circuit life span but also affect solute clearance. This evidence-based review critically examines the published rature on different vascular access sites, access types, and anticoagulation regimens, to provide clinical guidelines for good working practices and to direct future studies.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
